» Articles » PMID: 38764941

Therapeutic Strategies for Uncomplicated Cystitis in Women

Overview
Journal GMS Infect Dis
Date 2024 May 20
PMID 38764941
Authors
Affiliations
Soon will be listed here.
Abstract

Uncomplicated cystitis is affecting many women of all ages and has a great impact on the quality of life, especially in women suffering from recurrent, uncomplicated cystitis. By far the most frequent uropathogen, , may have acquired increasing resistance against a variety of oral antibiotics, which may differ between countries and regions. Therefore, local resistance data are important to be considered. On the other hand, non-antibiotic therapy has also become an option which should be discussed and offered to the patient. In patients suffering from recurrent uncomplicated cystitis, individual risk factors and possible behavioral changes should first be taken into account. Non-antimicrobial prophylactic strategies shown to be successful in well-designed clinical studies are the next options. Long term antibiotic prophylaxis, however, should only be considered as a last option. For some of those patients self-diagnosis and self-treatment may be suitable, e.g. by using a recognized questionnaire.

Citing Articles

Therapeutic strategies for uncomplicated cystitis in women.

Naber K, Alidjanov J, Funfstuck R, Strohmaier W, Kranz J, Cai T GMS Infect Dis. 2024; 12:Doc01.

PMID: 38764941 PMC: 11099625. DOI: 10.3205/id000086.

References
1.
Lenger S, Bradley M, Thomas D, Bertolet M, Lowder J, Sutcliffe S . D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am J Obstet Gynecol. 2020; 223(2):265.e1-265.e13. PMC: 7395894. DOI: 10.1016/j.ajog.2020.05.048. View

2.
Cai T, Anceschi U, Tamanini I, Migno S, Rizzo M, Liguori G . Xyloglucan, Hibiscus and Propolis in the Management of Uncomplicated Lower Urinary Tract Infections: A Systematic Review and Meta-Analysis. Antibiotics (Basel). 2022; 11(1). PMC: 8773311. DOI: 10.3390/antibiotics11010014. View

3.
Kaye K, Gupta V, Mulgirigama A, Joshi A, Scangarella-Oman N, Yu K . Antimicrobial Resistance Trends in Urine Escherichia coli Isolates From Adult and Adolescent Females in the United States From 2011 to 2019: Rising ESBL Strains and Impact on Patient Management. Clin Infect Dis. 2021; 73(11):1992-1999. PMC: 8664433. DOI: 10.1093/cid/ciab560. View

4.
Raz R, Stamm W . A controlled trial of intravaginal estriol in postmenopausal women with recurrent urinary tract infections. N Engl J Med. 1993; 329(11):753-6. DOI: 10.1056/NEJM199309093291102. View

5.
Naboka Y, Mavzyiutov A, Kogan M, Gudima I, Ivanov S, Naber K . Does Escherichia coli have pathogenic potential at a low level of bacteriuria in recurrent, uncomplicated urinary tract infection?. Int J Antimicrob Agents. 2020; 56(1):105983. DOI: 10.1016/j.ijantimicag.2020.105983. View